external quality assurance scheme

(redirected from external quality assessment scheme)

external quality assurance scheme

A UK system for auditing skills in certain specialties (e.g., histopathology and cytopathology) which plays a valuable role in helping to maintain high standards of diagnostic skills in consultants.
References in periodicals archive ?
Reference materials and analytical standards to stimulate improved laboratory performance: experience from the external quality assessment scheme for trace elements in biological samples.
The Cystic Fibrosis (CF) European Network (39) offers an external quality assessment scheme for CF molecular genetic testing to more than 200 laboratories worldwide.
Arctic Monitoring and Assessment Program (Institut National de Sante Publique du Quebec 2012), German External Quality Assessment Scheme (G-EQUAS; Social and Environmental Medicine of the University Erlangen-Nuremberg 2012)] and the use of standard reference materials (SRMs) from the National Institute of Standards and Technology (Keller et al.
Graham Carter and DEQAS, the Vitamin D External Quality Assessment Scheme, Dr.
Twenty laboratories from Latin America and the Caribbean are registered in a program sponsored by WHO called the International External Quality Assessment Scheme for Hematology.
2) In the year 2005, the Thailand National External Quality Assessment Scheme (NEQAS) for Blood Coagulation was founded with the encouragement of World Health Organization International External Quality Assessment Scheme for Blood Coagulation (WHO IEQAS), of which the Department of Clinical Pathology, Faculty of Medicine, Siriraj Hospital, is a member.
In 2003, also in honor of World Hemophilia Day, Bayer BP and the Kogenate(R) brand provided important financial support for a major WFH initiative, the International External Quality Assessment Scheme (IEQAS).
Nevertheless, results submitted to the international Vitamin D External Quality Assessment Scheme (DEQAS) have shown a gradual reduction in interlaboratory imprecision (CV) in recent years--from >30% in 1995 to 15% in 2011.
Therefore, it is not surprising that the results from the United Kingdom National External Quality Assessment Scheme for Immunocytochemistry (UK NEQAS-ICC) found that the lack of reproducibility of HER2 scoring between laboratories was not caused by tumor heterogeneity or differences in fixation or processing but rather by how the scoring system was applied (7).

Full browser ?